SELLAS Life Sciences Group Inc. (NASDAQ:SLS) and Intec Pharma Ltd. (NASDAQ:NTEC), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation of the two firms.
Earnings and Valuation
Table 1 shows the gross revenue, earnings per share (EPS) and valuation for SELLAS Life Sciences Group Inc. and Intec Pharma Ltd.
Table 2 provides us the return on assets, net margins and return on equity of both businesses.
Insider Institutional Ownership
The shares of both SELLAS Life Sciences Group Inc. and Intec Pharma Ltd. are owned by institutional investors at 31.1% and 39.64% respectively. About 1.9% of SELLAS Life Sciences Group Inc.’s share are owned by insiders. On the other hand, insiders owned about 11.81% of Intec Pharma Ltd.’s shares.
In this table we provide the Weekly,